Kathleen Borthwick
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Kathleen Borthwick
Kathleen Borthwick is recorded as CFO at Passage BIO, Inc. (PASG). Passage BIO, Inc. reported in an 8-K filed March 4, 2024 that Kathleen Borthwick was appointed Chief Financial Officer, effective March 1, 2024. Passage BIO, Inc. reported in an 8-K filed July 20, 2023 that Kathleen Borthwick was appointed Senior Vice President and Interim Chief Financial Officer, effective July 28, 2023.
“On March 1, 2024 (the "Effective Date"), Kathleen Borthwick, the Company's current Senior Vice President and Interim Chief Financial Officer was appointed to serve as Chief Financial Officer.”
“On July 15, 2023, Kathleen Borthwick, the current Vice President, Finance of the Company was appointed to serve as Senior Vice President and Interim Chief Financial Officer, effective on or about July 28, 2023 (the "Commencement Date").”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Start not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Passage BIO, Inc.
Other people whose current roles at this company are on record from its filings.
- Peter Smith, Ph.D. CEO
- William Chou CEO, Board Member
- William Chou, M.D. CEO, Board Member
- Maxine Gowen Chairman
- Athena Countouriotis Board Member
- Dolan Sondhi Board Member
- Dr. Maxine Gowen Board Member
- Dr. Michael Kamarck Board Member
- Thomas Kassberg Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.